What is the serum-ascitic albumin gradient (SAAG)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The serum-ascites albumin gradient (SAAG) is a diagnostic tool used to differentiate the causes of ascites by measuring the difference between serum albumin and ascitic fluid albumin concentrations. To calculate SAAG, subtract the ascitic fluid albumin level from the serum albumin level, with both measurements taken on the same day. A SAAG value ≥1.1 g/dL indicates portal hypertension as the cause of ascites, commonly seen in conditions like cirrhosis, alcoholic hepatitis, heart failure, and Budd-Chiari syndrome. A SAAG value <1.1 g/dL suggests non-portal hypertension causes such as peritoneal carcinomatosis, tuberculosis, pancreatitis, or nephrotic syndrome. This test is more accurate than the older exudate-transudate classification system, with approximately 97% accuracy in identifying portal hypertension-related ascites, as supported by the most recent guidelines from the American Association for the Study of Liver Diseases 1. The physiological basis for this gradient relates to oncotic pressure differences between the portal venous system and the ascitic fluid, which directly correlates with portal pressure. SAAG remains a cornerstone in the initial evaluation of patients with ascites and helps guide appropriate treatment strategies.

Some key points to consider when interpreting SAAG results include:

  • A high SAAG value (≥1.1 g/dL) is indicative of portal hypertension, which is often seen in cirrhosis, heart failure, and other conditions that affect the liver or portal venous system.
  • A low SAAG value (<1.1 g/dL) suggests non-portal hypertension causes of ascites, such as peritoneal carcinomatosis, tuberculosis, or pancreatitis.
  • The accuracy of SAAG in identifying portal hypertension-related ascites is approximately 97%, making it a valuable diagnostic tool in clinical practice, as noted in the guidelines from the American Association for the Study of Liver Diseases 1 and the Clinical Practice Guidelines for Liver Cirrhosis: Ascites and Related Complications 1.
  • SAAG should be calculated using simultaneously obtained serum and ascitic fluid samples, as recommended by the guidelines from the American Association for the Study of Liver Diseases 1 and the Clinical Practice Guidelines for Liver Cirrhosis: Ascites and Related Complications 1.

Overall, SAAG is a useful diagnostic tool that can help clinicians differentiate between portal hypertension and non-portal hypertension causes of ascites, and guide appropriate treatment strategies, as supported by the most recent and highest quality evidence from the American Association for the Study of Liver Diseases 1 and other reputable sources.

From the Research

Definition of Serum Ascitic Albumin Gradient

  • The serum-ascites albumin gradient (SAAG) is a diagnostic tool used to assess the cause of ascites, which is the accumulation of fluid in the peritoneal cavity 2.
  • SAAG is calculated by subtracting the albumin concentration in the ascitic fluid from the albumin concentration in the serum.
  • A high SAAG indicates portal hypertension, which is a common cause of ascites, while a low SAAG suggests other causes such as peritoneal carcinomatosis or tuberculous peritonitis.

Clinical Significance of SAAG

  • The diagnostic evaluation of ascites involves determining the SAAG to identify the underlying cause of the condition 2.
  • SAAG is used to differentiate between portal hypertensive and non-portal hypertensive causes of ascites.
  • A SAAG of 1.1 g/dL or higher indicates portal hypertension with a high degree of accuracy.

Management of Ascites

  • The management of ascites involves a combination of sodium restriction, diuretics, and other therapies such as large-volume paracentesis and transjugular intrahepatic portosystemic shunts 2, 3, 4.
  • The choice of treatment depends on the underlying cause of ascites, the severity of the condition, and the presence of complications such as spontaneous bacterial peritonitis or hepatorenal syndrome.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Ascites: diagnosis and management.

The Medical clinics of North America, 2009

Research

Treatment of ascites and its complications.

Duodecim; laaketieteellinen aikakauskirja, 2016

Related Questions

What is the significance of creatinine (a waste product) levels in ascites (fluid accumulation in the peritoneal cavity)?
What are the alternatives to Spironolactone (spironolactone) for treating ascites?
What is the management plan for a 56-year-old female with moderate ascites and minimal pleural effusion due to hepatic parenchymal disease?
How to evaluate and manage abdominal ascites?
What is the role of acetazolamide (carbonic anhydrase inhibitor) in conjunction with paracentesis for managing ascites?
What is the nursing diagnosis for a patient with chest pain, hypercholesterolemia, hypertension, obesity (Body Mass Index (BMI) 32.7), type 2 diabetes, and a family history of cardiovascular disease (CVD), who smokes 15 cigarettes per day and consumes 5-6 alcoholic beverages per day, and is prescribed Glyceryl Trinitrate (GTN) and Morphine as needed (PRN) for chest pain?
What are the key differences, clinical manifestations, and management strategies for Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic State (HHS), including insulin therapy and laboratory monitoring?
What are the causes of thrombosis (blood clot formation)?
Is Amoxicillin (amoxicillin) effective for treating dental infections?
What is the role of corticosteroids (steroids) in treating vertigo (benign paroxysmal positional vertigo)?
Is treatment warranted for an 85-year-old male with a history of prediabetes (impaired glucose regulation), erectile dysfunction (ED), hypertension (HTN), benign prostatic hyperplasia (BPH), and a previous cerebral infarction (stroke) with gait instability, who remains in the prediabetic range?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.